Analysis of molecular mechanism of HPV18 carcinogenesis by transcriptome sequencing
RNA-seq (gene expression) · human · 18 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 18 samples: 6 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE234041_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA979227 and SRA study SRP440967. Searching any of these in the dataset finder brings you back here.
Supports a case/control comparison: 3 samples read as cases, 9 as controls.
How we read this: 6 replicated groups read from 18 sample titles; they account for 18 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM7441549 normal cervical epithelial cells group, control, day1, Rep1 normal cervical epithel…
- GSM7441550 normal cervical epithelial cells group, control, day1, Rep2 normal cervical epithel…
- GSM7441551 normal cervical epithelial cells group, control, day1, Rep3 normal cervical epithel…
- GSM7441552 normal cervical epithelial cells group, β-estradiol stimulation, day1, Rep1 normal cervical epithel…
- GSM7441553 normal cervical epithelial cells group, β-estradiol stimulation, day1, Rep2 normal cervical epithel…
- GSM7441554 normal cervical epithelial cells group, β-estradiol stimulation, day1, Rep3 normal cervical epithel…
- GSM7441555 cervical intraepithelial Neoplasia HPV18 cells group, control, day1, Rep1 cervical intraepithelia…
- GSM7441556 cervical intraepithelial Neoplasia HPV18 cells group, control, day1, Rep2 cervical intraepithelia…
- GSM7441557 cervical intraepithelial Neoplasia HPV18 cells group, control, day1, Rep3 cervical intraepithelia…
- GSM7441558 cervical intraepithelial Neoplasia HPV18 cells group, β-estradiol stimulation, day1, Rep1 cervical intraepithelia…
- GSM7441559 cervical intraepithelial Neoplasia HPV18 cells group, β-estradiol stimulation, day1, Rep2 cervical intraepithelia…
- GSM7441560 cervical intraepithelial Neoplasia HPV18 cells group, β-estradiol stimulation, day1, Rep3 cervical intraepithelia…
- GSM7441561 patient-derived cervical cancer cell group, control, day1, Rep1 patient-derived cervica…
- GSM7441562 patient-derived cervical cancer cell group, control, day1, Rep2 patient-derived cervica…
- GSM7441563 patient-derived cervical cancer cell group, control, day1, Rep3 patient-derived cervica…
- GSM7441564 patient-derived cervical cancer cell group, β-estradiol stimulation, day1, Rep1 patient-derived cervica…
- GSM7441565 patient-derived cervical cancer cell group, β-estradiol stimulation, day1, Rep2 patient-derived cervica…
- GSM7441566 patient-derived cervical cancer cell group, β-estradiol stimulation, day1, Rep3 patient-derived cervica…
- GSE285710 Site-Specific HPV18 Integration Facilitates Cervical Carcinogenesis through metabolic reprogramming-Induced dysfunction of the SpHK1/S1P/S1PR1 pathway 24 samples shares hpv18, carcinogenesis
- GSE285796 Site-Specific HPV18 Integration Facilitates Cervical Carcinogenesis through metabolic reprogramming-Induced dysfunction of the SpHK1/S1P/S1PR1 pathway-part2 6 samples shares hpv18, carcinogenesis
- GSE249929 Integrated HPV18 acts as enhancer-like RNA and form phase-separated condensates to promote oncogenic genes expression. 12 samples shares hpv18
- GSE143584 Gene expression from laser capture microdissected epithelium and stroma during pancreatic carcinogenesis 366 samples shares carcinogenesis
- GSE336982 Obesity Promotes Lung Carcinogenesis Through Airway Immune Dysfunction 183 samples shares carcinogenesis
- GSE275345 A distinct mechanism of epigenetic reprogramming silences PAX2 and initiates endometrial carcinogenesis 15 samples shares carcinogenesis
- GSE161277 Dissecting the Epithelial and Immune Evolution during Colorectal Carcinogenesis by Single-Cell RNA Sequencing 13 samples shares carcinogenesis
- GSE275309 A distinct mechanism of epigenetic reprogramming silences PAX2 and initiates endometrial carcinogenesis 6 samples shares carcinogenesis
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.